Clinical trials
Phase 3 trials in South Korea with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
218 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 13 |
| 2010 | 13 |
| 2011 | 9 |
| 2012 | 15 |
| 2013 | 17 |
| 2014 | 13 |
| 2015 | 19 |
| 2016 | 16 |
| 2017 | 8 |
| 2018 | 15 |
| 2019 | 11 |
| 2020 | 11 |
| 2021 | 16 |
| 2022 | 8 |
| 2023 | 10 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 218 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 26 |
| Seoul National University Hospital | 17 |
| Chong Kun Dang Pharmaceutical | 12 |
| Yonsei University | 12 |
| Asan Medical Center | 10 |
| Daewoong Pharmaceutical Co. LTD. | 8 |
| IlDong Pharmaceutical Co Ltd | 6 |
| National Cancer Center, Korea | 6 |
| Kyunghee University Medical Center | 5 |
| Yooyoung Pharmaceutical Co., Ltd. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 12 |
| Hypertension | 10 |
| Breast Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Hepatitis B, Chronic | 5 |
| Ischemic Stroke | 5 |
| Ovarian Neoplasms | 5 |
| Fallopian Tube Neoplasms | 4 |
| Neoplasms | 4 |
Trials
Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.
118 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.